Simple SummaryDespite massive strides taken across the board in oncology, there remain gaps in understanding the relationship between cancer cells and the body’s immune system, tissues, and signaling pathways.
Scientists at the University of California, Irvine’s School of Pharmacy & Pharmaceutical Sciences have discovered how muscle stem cells “flip a switch” to rebuild damaged muscle—a finding that could help address muscle loss linked to aging, injury and widely used weight-loss medications.
The study, published this week in Nature Metabolism, shows that muscle recovery is not just about protein or exercise. It depends on timing and how muscle cells use fuel.
Researchers learned that immediately after stress, muscle stem cells temporarily slow down energy production. Instead of burning glucose for energy, they reroute it into protective repair processes to produce antioxidants that reduce inflammation. Once repairs are complete, energy production ramps back up and new muscle fibers form and strengthen.
When it comes to health, some of our animal neighbors have extraordinary advantages. Ostriches, for example, are highly resistant to viruses, while sharks rarely develop cancer. And species like naked mole rats and bowhead whales live for astonishingly long periods of time, decades and centuries, respectively.
Researchers are now starting to understand why another species—the golden spiny mouse—seems to be unhindered by the negative health effects that typically accompany aging.
Reporting in Science Advances, researchers at Yale School of Medicine (YSM) have begun to uncover how this wild mouse, native to rocky deserts in the Middle East, resists physical, cognitive, and immunological decline while living six to seven times longer than other wild mice.
Varicella zoster virus (VZV) infection causes varicella and herpes zoster and, rarely, severe central nervous system (CNS) complications, including encephalitis. Ogunjimi et al. review the evidence linking herpes zoster with stroke and dementia, summarize innate and adaptive immune responses to VZV-related CNS disease, and debate the consequences of vaccination.
Unlike treatments that focus on removing plaques that have already formed, levetiracetam works differently. It blocks the production of toxic amyloid beta peptides in the first place.
Your gut bacteria are chemical detectives—sniffing out nutrients and even feeding each other to keep your microbiome thriving. Your gut is home to trillions of bacteria that constantly “sense” their surroundings to survive and thrive. New research shows that beneficial gut microbes, especially common Clostridia bacteria, can detect a surprisingly wide range of chemical signals produced during digestion, including byproducts of fats, proteins, sugars, and even DNA. These microbes use specialized sensors to move toward valuable nutrients, with lactate and formate standing out as especially important fuel sources.
The gut microbiome, also called the gut flora, plays a vital role in human health. This enormous and constantly changing community of microorganisms is shaped by countless chemical exchanges, both among the microbes themselves and between microbes and the human body. For these interactions to work, gut bacteria must be able to detect nutrients and chemical signals around them. Despite their importance, scientists still know relatively little about the full range of signals that bacterial receptors can recognize.
A key question remains. Which chemical signals matter most to beneficial gut bacteria?
Group B streptococcus commonly colonizes the human gastrointestinal and genitourinary tracts and is the single most common bacterial cause of invasive infection among newborns in the United States. Intrapartum antibiotic prophylaxis is currently used to reduce the risk of group B streptococcal disease among pregnant persons and newborns. No strategies are currently available to prevent disease in later infancy or among nonpregnant adults. Vaccines against group B streptococcal disease that consist of capsular polysaccharides linked to protein antigens are in development and may provide a means of prevention for all at-risk populations.
Medical researchers have discovered that semaglutide may reverse the debilitating tissue damage caused by osteoarthritis, the world’s most common form of arthritis.
The drug behind Ozempic and Wegovy is best known for treating type 2 diabetes and helping people lose weight. But the new study found semaglutide appears to protect joints in mice through a mechanism that’s not about easing pressure through weight loss.
Instead, the drug reprograms the metabolism of cells that synthesize and maintain healthy cartilage, allowing them to generate more energy.